FIELD: pharmaceutical industry. SUBSTANCE: composition contains 0.004-0.040 g 2- benzimidazol hydrochloride, 0.025-0.100 g ascorbic acid, and 0.0005-0.005 g L-glutamyl-L-tryptophan monosodium salt as immunomodulating component per 1 dosed therapeutic unit. EFFECT: simplified administration and increased efficiency in treatment of diseases caused by interferon-sensitive viruses. 6 dwg, 2 tbl, 3 ex
Authors
Dates
2001-04-20—Published
1999-01-20—Filed